HomeNewsTrendsEntertainmentGrammys 2022: BTS’ Jungkook recovers from COVID-19, to join other band members for performance
Trending Topics

Grammys 2022: BTS’ Jungkook recovers from COVID-19, to join other band members for performance

Grammys 2022: South Korean band BTS have been nominated in the best pop duo/group performance category for their English single "Butter".

April 03, 2022 / 14:13 IST
Story continues below Advertisement
Grammys 2022: Jungkook (fourth from left) had tested positive for coronavirus on March 28 after arriving in Las Vegas for the awards.
Grammys 2022: Jungkook (fourth from left) had tested positive for coronavirus on March 28 after arriving in Las Vegas for the awards.

BTS member Jungkook has recovered from COVID-19 and is set to perform at the 2022 Grammy Awards, the South Korean band's management agency said on Sunday.

The 24-year-old vocalist, who tested positive for the virus on March 28 after arriving in Las Vegas for the awards ceremony, was released from quarantine on Saturday.

Story continues below Advertisement

"We would like to inform you that BTS member Jungkook has made a full recovery from COVID-19 and his quarantine has concluded as of Saturday,” BigHit Music said. “Jungkook has been under self-quarantine and administering self-treatment since last Sunday, and in accordance with the guidelines of health authorities in the United States, Jungkook can resume his daily activities from today.”

Upon conclusion of the quarantine, Jungkook took a rapid antigen test in the US to join the schedule for the Grammy Awards. "The result came back negative, and the awards organizer has approved of his Grammy Awards participation," the agency further said. "

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show